The Market Reports
Call: +1-631-407-1315 / +91-750-729-1479
Email: sales@themarketreports.com
Canine Arthritis Treatment-Global Market Insights and Sales Trends 2024
Synopsis
The canine arthritis treatment types include non-steroidal anti-inflammatory medications (NSAIDs), opioids and stem cell Canine Arthritis Treatment. Non-steroidal anti-inflammatory Canine Arthritis Treatment are used to control pain and inflammation associated with arthritis. They are most commonly used canine arthritis treatment drugs. NSAIDs are used to treat mild to moderate pain by reducing the production of prostaglandins, which is involved with inflammation and discomfort. Several non-steroidal anti-inflammatory medications approved for canine arthritis treatment are Ketaprofen, Carprofen, Deracoxib, and Rimadyl, among others. Opioids are another class of pain relief medication for canine arthritis treatment, which includes Tramadol, Tapentadol, and buprenorphine, among others. Opioids work by acting through the central opioid receptors. They are used to treat moderate to severe as well as chronic pain associated with arthritis. The stem cell therapy is a new treatment option for canine arthritis treatment. The stem cell Canine Arthritis Treatment is usually performed as canine arthritis treatment using either autologous stem cells or allogeneic stem cells Canine Arthritis Treatment. In the stem cell canine arthritis treatment, the adult stem cells are harvested from canine’s fat tissues and injected into the affected joints. The stem cell Canine Arthritis Treatment has improved the quality of life of canines by reducing pain and increasing mobility and has shown 85% success rate within 5 months of canine arthritis treatment.
The global Canine Arthritis Treatment market size is expected to reach US$ million by 2029, growing at a CAGR of % from 2023 to 2029. The market is mainly driven by the significant applications of Canine Arthritis Treatment in various end use industries. The expanding demands from the Veterinary Hospitals and Clinics, Drug Stores and E-commerce,, are propelling Canine Arthritis Treatment market. Non-Steroidal Anti-Inflammatory Drugs, one of the segments analysed in this report, is projected to record % CAGR and reach US$ million by the end of the analysis period. Growth in the Opioids segment is estimated at % CAGR for the next seven-year period.
The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during the next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, the chemical drug market is estimated to increase from 1005 billion in 2018 to 1094 billion U.S. dollars in 2022. The pharmaceutical market factors such as increasing demand for healthcare, technological advancements, and the rising prevalence of chronic diseases, increase in funding from private & government organizations for development of pharmaceutical manufacturing segments and rise in R&D activities for drugs. However, the industry also faces challenges such as stringent regulations, high costs of research and development, and patent expirations. Companies need to continuously innovate and adapt to these challenges to stay competitive in the market and ensure their products reach patients in need. Additionally, the COVID-19 pandemic has highlighted the importance of vaccine development and supply chain management, further emphasizing the need for pharmaceutical companies to be agile and responsive to emerging public health needs.
Report Objectives
This report provides market insight on the different segments, by players, by Type, by Application. Market size and forecast (2018-2029) has been provided in the report. The primary objectives of this report are to provide 1) global market size and forecasts, growth rates, market dynamics, industry structure and developments, market situation, trends; 2) global market share and ranking by company; 3) comprehensive presentation of the global market for Canine Arthritis Treatment, with both quantitative and qualitative analysis through detailed segmentation; 4) detailed value chain analysis and review of growth factors essential for the existing market players and new entrants; 5) emerging opportunities in the market and the future impact of major drivers and restraints of the market.
Key Features of The Study:
This report provides in-depth analysis of the global Canine Arthritis Treatment market, and provides market size (US$ million) and CAGR for the forecast period (2023-2029), considering 2022 as the base year.
This report profiles key players in the global Canine Arthritis Treatment market based on the following parameters - company details (found date, headquarters, manufacturing bases), products portfolio, Canine Arthritis Treatment sales data, market share and ranking.
This report elucidates potential market opportunities across different segments and explains attractive investment proposition matrices for this market.
This report illustrates key insights about market drivers, restraints, opportunities, market trends, regional outlook.
Key companies of Canine Arthritis Treatment covered in this report include Elanco (Eli Lilly and Company), Boehringer Ingelheim, Zoetis Inc, Vetoquinol S.A., Bayer AG, Aratana Therapeutics Inc, Norbrook Laboratories Limited, VetStem Biopharma and Dechra Pharmaceuticals Plc, etc.
The global Canine Arthritis Treatment market report caters to various stakeholders in this industry including investors, suppliers, product players, distributors, new entrants, and financial analysts.
Market Segmentation
Company Profiles:
Elanco (Eli Lilly and Company)
Boehringer Ingelheim
Zoetis Inc
Vetoquinol S.A.
Bayer AG
Aratana Therapeutics Inc
Norbrook Laboratories Limited
VetStem Biopharma
Dechra Pharmaceuticals Plc
Global Canine Arthritis Treatment market, by region:
North America (U.S., Canada, Mexico)
Europe (Germany, France, UK, Italy, etc.)
Asia Pacific (China, Japan, South Korea, Southeast Asia, India, etc.)
South America (Brazil, etc.)
Middle East and Africa (Turkey, GCC Countries, Africa, etc.)
Global Canine Arthritis Treatment market, Segment by Type:
Non-Steroidal Anti-Inflammatory Drugs
Opioids
Global Canine Arthritis Treatment market, by Application
Veterinary Hospitals and Clinics
Drug Stores
E-commerce
Core Chapters
Chapter One: Introduces the report scope of the report, executive summary of global and regional market size and CAGR for the history and forecast period (2018-2023, 2024-2029). It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter Two: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter Three: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter Four: Detailed analysis of Canine Arthritis Treatment companies’ competitive landscape, revenue, market share and ranking, latest development plan, merger, and acquisition information, etc.
Chapter Five: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product introduction, revenue, recent development, etc.
Chapter Six, Seven, Eight, Nine and Ten: North America, Europe, Asia Pacific, Latin America, Middle East & Africa, revenue by country.
Chapter Eleven: this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter Twelve: Research Finding/Conclusion
The canine arthritis treatment types include non-steroidal anti-inflammatory medications (NSAIDs), opioids and stem cell Canine Arthritis Treatment. Non-steroidal anti-inflammatory Canine Arthritis Treatment are used to control pain and inflammation associated with arthritis. They are most commonly used canine arthritis treatment drugs. NSAIDs are used to treat mild to moderate pain by reducing the production of prostaglandins, which is involved with inflammation and discomfort. Several non-steroidal anti-inflammatory medications approved for canine arthritis treatment are Ketaprofen, Carprofen, Deracoxib, and Rimadyl, among others. Opioids are another class of pain relief medication for canine arthritis treatment, which includes Tramadol, Tapentadol, and buprenorphine, among others. Opioids work by acting through the central opioid receptors. They are used to treat moderate to severe as well as chronic pain associated with arthritis. The stem cell therapy is a new treatment option for canine arthritis treatment. The stem cell Canine Arthritis Treatment is usually performed as canine arthritis treatment using either autologous stem cells or allogeneic stem cells Canine Arthritis Treatment. In the stem cell canine arthritis treatment, the adult stem cells are harvested from canine’s fat tissues and injected into the affected joints. The stem cell Canine Arthritis Treatment has improved the quality of life of canines by reducing pain and increasing mobility and has shown 85% success rate within 5 months of canine arthritis treatment.
The global Canine Arthritis Treatment market size is expected to reach US$ million by 2029, growing at a CAGR of % from 2023 to 2029. The market is mainly driven by the significant applications of Canine Arthritis Treatment in various end use industries. The expanding demands from the Veterinary Hospitals and Clinics, Drug Stores and E-commerce,, are propelling Canine Arthritis Treatment market. Non-Steroidal Anti-Inflammatory Drugs, one of the segments analysed in this report, is projected to record % CAGR and reach US$ million by the end of the analysis period. Growth in the Opioids segment is estimated at % CAGR for the next seven-year period.
The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during the next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, the chemical drug market is estimated to increase from 1005 billion in 2018 to 1094 billion U.S. dollars in 2022. The pharmaceutical market factors such as increasing demand for healthcare, technological advancements, and the rising prevalence of chronic diseases, increase in funding from private & government organizations for development of pharmaceutical manufacturing segments and rise in R&D activities for drugs. However, the industry also faces challenges such as stringent regulations, high costs of research and development, and patent expirations. Companies need to continuously innovate and adapt to these challenges to stay competitive in the market and ensure their products reach patients in need. Additionally, the COVID-19 pandemic has highlighted the importance of vaccine development and supply chain management, further emphasizing the need for pharmaceutical companies to be agile and responsive to emerging public health needs.
Report Objectives
This report provides market insight on the different segments, by players, by Type, by Application. Market size and forecast (2018-2029) has been provided in the report. The primary objectives of this report are to provide 1) global market size and forecasts, growth rates, market dynamics, industry structure and developments, market situation, trends; 2) global market share and ranking by company; 3) comprehensive presentation of the global market for Canine Arthritis Treatment, with both quantitative and qualitative analysis through detailed segmentation; 4) detailed value chain analysis and review of growth factors essential for the existing market players and new entrants; 5) emerging opportunities in the market and the future impact of major drivers and restraints of the market.
Key Features of The Study:
This report provides in-depth analysis of the global Canine Arthritis Treatment market, and provides market size (US$ million) and CAGR for the forecast period (2023-2029), considering 2022 as the base year.
This report profiles key players in the global Canine Arthritis Treatment market based on the following parameters - company details (found date, headquarters, manufacturing bases), products portfolio, Canine Arthritis Treatment sales data, market share and ranking.
This report elucidates potential market opportunities across different segments and explains attractive investment proposition matrices for this market.
This report illustrates key insights about market drivers, restraints, opportunities, market trends, regional outlook.
Key companies of Canine Arthritis Treatment covered in this report include Elanco (Eli Lilly and Company), Boehringer Ingelheim, Zoetis Inc, Vetoquinol S.A., Bayer AG, Aratana Therapeutics Inc, Norbrook Laboratories Limited, VetStem Biopharma and Dechra Pharmaceuticals Plc, etc.
The global Canine Arthritis Treatment market report caters to various stakeholders in this industry including investors, suppliers, product players, distributors, new entrants, and financial analysts.
Market Segmentation
Company Profiles:
Elanco (Eli Lilly and Company)
Boehringer Ingelheim
Zoetis Inc
Vetoquinol S.A.
Bayer AG
Aratana Therapeutics Inc
Norbrook Laboratories Limited
VetStem Biopharma
Dechra Pharmaceuticals Plc
Global Canine Arthritis Treatment market, by region:
North America (U.S., Canada, Mexico)
Europe (Germany, France, UK, Italy, etc.)
Asia Pacific (China, Japan, South Korea, Southeast Asia, India, etc.)
South America (Brazil, etc.)
Middle East and Africa (Turkey, GCC Countries, Africa, etc.)
Global Canine Arthritis Treatment market, Segment by Type:
Non-Steroidal Anti-Inflammatory Drugs
Opioids
Global Canine Arthritis Treatment market, by Application
Veterinary Hospitals and Clinics
Drug Stores
E-commerce
Core Chapters
Chapter One: Introduces the report scope of the report, executive summary of global and regional market size and CAGR for the history and forecast period (2018-2023, 2024-2029). It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter Two: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter Three: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter Four: Detailed analysis of Canine Arthritis Treatment companies’ competitive landscape, revenue, market share and ranking, latest development plan, merger, and acquisition information, etc.
Chapter Five: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product introduction, revenue, recent development, etc.
Chapter Six, Seven, Eight, Nine and Ten: North America, Europe, Asia Pacific, Latin America, Middle East & Africa, revenue by country.
Chapter Eleven: this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter Twelve: Research Finding/Conclusion
Index1 Market Overview of Canine Arthritis Treatment
1.1 Canine Arthritis Treatment Market Overview
1.1.1 Canine Arthritis Treatment Product Scope
1.1.2 Canine Arthritis Treatment Market Status and Outlook
1.2 Global Canine Arthritis Treatment Market Size Overview by Region 2018 VS 2022 VS 2029
1.3 Global Canine Arthritis Treatment Market Size by Region (2018-2029)
1.4 Global Canine Arthritis Treatment Historic Market Size by Region (2018-2023)
1.5 Global Canine Arthritis Treatment Market Size Forecast by Region (2024-2029)
1.6 Key Regions, Canine Arthritis Treatment Market Size (2018-2029)
1.6.1 North America Canine Arthritis Treatment Market Size (2018-2029)
1.6.2 Europe Canine Arthritis Treatment Market Size (2018-2029)
1.6.3 Asia-Pacific Canine Arthritis Treatment Market Size (2018-2029)
1.6.4 Latin America Canine Arthritis Treatment Market Size (2018-2029)
1.6.5 Middle East & Africa Canine Arthritis Treatment Market Size (2018-2029)
2 Canine Arthritis Treatment Market by Type
2.1 Introduction
2.1.1 Non-Steroidal Anti-Inflammatory Drugs
2.1.2 Opioids
2.2 Global Canine Arthritis Treatment Market Size by Type: 2018 VS 2022 VS 2029
2.2.1 Global Canine Arthritis Treatment Historic Market Size by Type (2018-2023)
2.2.2 Global Canine Arthritis Treatment Forecasted Market Size by Type (2024-2029)
2.3 Key Regions Market Size by Type
2.3.1 North America Canine Arthritis Treatment Revenue Breakdown by Type (2018-2029)
2.3.2 Europe Canine Arthritis Treatment Revenue Breakdown by Type (2018-2029)
2.3.3 Asia-Pacific Canine Arthritis Treatment Revenue Breakdown by Type (2018-2029)
2.3.4 Latin America Canine Arthritis Treatment Revenue Breakdown by Type (2018-2029)
2.3.5 Middle East and Africa Canine Arthritis Treatment Revenue Breakdown by Type (2018-2029)
3 Canine Arthritis Treatment Market Overview by Application
3.1 Introduction
3.1.1 Veterinary Hospitals and Clinics
3.1.2 Drug Stores
3.1.3 E-commerce
3.2 Global Canine Arthritis Treatment Market Size by Application: 2018 VS 2022 VS 2029
3.2.1 Global Canine Arthritis Treatment Historic Market Size by Application (2018-2023)
3.2.2 Global Canine Arthritis Treatment Forecasted Market Size by Application (2024-2029)
3.3 Key Regions Market Size by Application
3.3.1 North America Canine Arthritis Treatment Revenue Breakdown by Application (2018-2029)
3.3.2 Europe Canine Arthritis Treatment Revenue Breakdown by Application (2018-2029)
3.3.3 Asia-Pacific Canine Arthritis Treatment Revenue Breakdown by Application (2018-2029)
3.3.4 Latin America Canine Arthritis Treatment Revenue Breakdown by Application (2018-2029)
3.3.5 Middle East and Africa Canine Arthritis Treatment Revenue Breakdown by Application (2018-2029)
4 Canine Arthritis Treatment Competition Analysis by Players
4.1 Global Canine Arthritis Treatment Market Size by Players (2018-2023)
4.2 Global Top Players by Company Type (Tier 1, Tier 2 and Tier 3) & (based on the Revenue in Canine Arthritis Treatment as of 2022)
4.3 Date of Key Players Enter into Canine Arthritis Treatment Market
4.4 Global Top Players Canine Arthritis Treatment Headquarters and Area Served
4.5 Key Players Canine Arthritis Treatment Product Solution and Service
4.6 Competitive Status
4.6.1 Canine Arthritis Treatment Market Concentration Rate
4.6.2 Mergers & Acquisitions, Expansion Plans
5 Company (Top Players) Profiles
5.1 Elanco (Eli Lilly and Company)
5.1.1 Elanco (Eli Lilly and Company) Profile
5.1.2 Elanco (Eli Lilly and Company) Main Business
5.1.3 Elanco (Eli Lilly and Company) Canine Arthritis Treatment Products, Services and Solutions
5.1.4 Elanco (Eli Lilly and Company) Canine Arthritis Treatment Revenue (US$ Million) & (2018-2023)
5.1.5 Elanco (Eli Lilly and Company) Recent Developments
5.2 Boehringer Ingelheim
5.2.1 Boehringer Ingelheim Profile
5.2.2 Boehringer Ingelheim Main Business
5.2.3 Boehringer Ingelheim Canine Arthritis Treatment Products, Services and Solutions
5.2.4 Boehringer Ingelheim Canine Arthritis Treatment Revenue (US$ Million) & (2018-2023)
5.2.5 Boehringer Ingelheim Recent Developments
5.3 Zoetis Inc
5.3.1 Zoetis Inc Profile
5.3.2 Zoetis Inc Main Business
5.3.3 Zoetis Inc Canine Arthritis Treatment Products, Services and Solutions
5.3.4 Zoetis Inc Canine Arthritis Treatment Revenue (US$ Million) & (2018-2023)
5.3.5 Vetoquinol S.A. Recent Developments
5.4 Vetoquinol S.A.
5.4.1 Vetoquinol S.A. Profile
5.4.2 Vetoquinol S.A. Main Business
5.4.3 Vetoquinol S.A. Canine Arthritis Treatment Products, Services and Solutions
5.4.4 Vetoquinol S.A. Canine Arthritis Treatment Revenue (US$ Million) & (2018-2023)
5.4.5 Vetoquinol S.A. Recent Developments
5.5 Bayer AG
5.5.1 Bayer AG Profile
5.5.2 Bayer AG Main Business
5.5.3 Bayer AG Canine Arthritis Treatment Products, Services and Solutions
5.5.4 Bayer AG Canine Arthritis Treatment Revenue (US$ Million) & (2018-2023)
5.5.5 Bayer AG Recent Developments
5.6 Aratana Therapeutics Inc
5.6.1 Aratana Therapeutics Inc Profile
5.6.2 Aratana Therapeutics Inc Main Business
5.6.3 Aratana Therapeutics Inc Canine Arthritis Treatment Products, Services and Solutions
5.6.4 Aratana Therapeutics Inc Canine Arthritis Treatment Revenue (US$ Million) & (2018-2023)
5.6.5 Aratana Therapeutics Inc Recent Developments
5.7 Norbrook Laboratories Limited
5.7.1 Norbrook Laboratories Limited Profile
5.7.2 Norbrook Laboratories Limited Main Business
5.7.3 Norbrook Laboratories Limited Canine Arthritis Treatment Products, Services and Solutions
5.7.4 Norbrook Laboratories Limited Canine Arthritis Treatment Revenue (US$ Million) & (2018-2023)
5.7.5 Norbrook Laboratories Limited Recent Developments
5.8 VetStem Biopharma
5.8.1 VetStem Biopharma Profile
5.8.2 VetStem Biopharma Main Business
5.8.3 VetStem Biopharma Canine Arthritis Treatment Products, Services and Solutions
5.8.4 VetStem Biopharma Canine Arthritis Treatment Revenue (US$ Million) & (2018-2023)
5.8.5 VetStem Biopharma Recent Developments
5.9 Dechra Pharmaceuticals Plc
5.9.1 Dechra Pharmaceuticals Plc Profile
5.9.2 Dechra Pharmaceuticals Plc Main Business
5.9.3 Dechra Pharmaceuticals Plc Canine Arthritis Treatment Products, Services and Solutions
5.9.4 Dechra Pharmaceuticals Plc Canine Arthritis Treatment Revenue (US$ Million) & (2018-2023)
5.9.5 Dechra Pharmaceuticals Plc Recent Developments
6 North America
6.1 North America Canine Arthritis Treatment Market Size by Country (2018-2029)
6.2 United States
6.3 Canada
7 Europe
7.1 Europe Canine Arthritis Treatment Market Size by Country (2018-2029)
7.2 Germany
7.3 France
7.4 U.K.
7.5 Italy
7.6 Russia
7.7 Nordic Countries
7.8 Rest of Europe
8 Asia-Pacific
8.1 Asia-Pacific Canine Arthritis Treatment Market Size by Region (2018-2029)
8.2 China
8.3 Japan
8.4 South Korea
8.5 Southeast Asia
8.6 India
8.7 Australia
8.8 Rest of Asia-Pacific
9 Latin America
9.1 Latin America Canine Arthritis Treatment Market Size by Country (2018-2029)
9.2 Mexico
9.3 Brazil
9.4 Rest of Latin America
10 Middle East & Africa
10.1 Middle East & Africa Canine Arthritis Treatment Market Size by Country (2018-2029)
10.2 Turkey
10.3 Saudi Arabia
10.4 UAE
10.5 Rest of Middle East & Africa
11 Canine Arthritis Treatment Market Dynamics
11.1 Canine Arthritis Treatment Industry Trends
11.2 Canine Arthritis Treatment Market Drivers
11.3 Canine Arthritis Treatment Market Challenges
11.4 Canine Arthritis Treatment Market Restraints
12 Research Finding /Conclusion
13 Methodology and Data Source
13.1 Methodology/Research Approach
13.1.1 Research Programs/Design
13.1.2 Market Size Estimation
13.1.3 Market Breakdown and Data Triangulation
13.2 Data Source
13.2.1 Secondary Sources
13.2.2 Primary Sources
13.3 Disclaimer
13.4 Author List
Published By : QY Research
Why ‘The Market Reports’
In Business:
Pre Sales Support:
Post Sales Support:
Turn Around Time:
Clients Served:
Clients Assisted:
Client Types:
Payment:
- Accept global payments [Credit Card / PayPal / Wire Transfer]
- Accept local payments in South Korea, Germany, China and India [Can pay in local currency]
Latest Life Science Market Reports
Payments Accepted From
Connect with us at
Complete Secure Website
